European Consensus Meeting on Foam Sclerotherapy, April, 4-6, 2003, Tegernsee, Germany
- PMID: 15099312
- DOI: 10.1111/j.1524-4725.2004.30209.x
European Consensus Meeting on Foam Sclerotherapy, April, 4-6, 2003, Tegernsee, Germany
Abstract
Background: The introduction of sclerotherapy using foam sclerosants has revitalized interest in this method of treating varicose veins. Foam is made from detergent-type sclerosants already established as safe and effective in conventional liquid sclerotherapy.
Objective: European experts in foam sclerotherapy were invited to exchange their opinions and to work on consensus statements and recommendations.
Methods: A questionnaire covering different areas of foam sclerotherapy was sent to experts who have published or presented data, participated in clinical trials, or otherwise contributed to sclerotherapy with extemporary (self-made) foam. Based on the answers, several consensus statements and recommendations were approved during the consensus meeting.
Results: The use of sclerosing foam is an appropriate procedure in the treatment of varicose veins. It is a powerful tool in the hands of an expert who has sufficient experience in sclerotherapy. Sclerosing foam is more powerful than liquid. Most recommendations for conventional liquid sclerotherapy also apply to foam sclerotherapy. Some differences between these two treatments were highlighted.
Conclusion: Foam sclerotherapy is a variation of a well-established treatment that improves varicose vein management. European experts came together to harmonize their opinions about sclerosing foam. The final document reflects the experts' opinion with the aim of defining principles for a safe and effective use of sclerosing foam and for its practical application. Foam sclerotherapy allows a skilled practitioner to treat larger veins including saphenous trunks.
Similar articles
-
2nd European Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany.Vasa. 2008 Feb;37 Suppl 71:1-29. Vasa. 2008. PMID: 18426039
-
Preliminary experience with a new sclerosing foam in the treatment of varicose veins.Dermatol Surg. 2001 Jan;27(1):58-60. Dermatol Surg. 2001. PMID: 11231246
-
Duplex ultrasound and efficacy criteria in foam sclerotherapy from the 2nd European Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany.Vasa. 2008 Feb;37(1):90-5. doi: 10.1024/0301-1526.37.1.90. Vasa. 2008. PMID: 18512547
-
Review of published information on foam sclerotherapy.Dermatol Surg. 2010 Jun;36 Suppl 2:983-92. doi: 10.1111/j.1524-4725.2009.01406.x. Dermatol Surg. 2010. PMID: 20590705 Review.
-
Foam sclerotherapy--a possible option in therapy of varicose veins.J Dtsch Dermatol Ges. 2007 Aug;5(8):648-54. doi: 10.1111/j.1610-0387.2007.06310.x. J Dtsch Dermatol Ges. 2007. PMID: 17659037 Review. English, German.
Cited by
-
Prolonged acute migraine with aura and reversible brain MRI abnormalities after liquid sclerotherapy.J Headache Pain. 2014 Jun 19;15(1):41. doi: 10.1186/1129-2377-15-41. J Headache Pain. 2014. PMID: 24948446 Free PMC article.
-
Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO).Eur Radiol. 2011 Jan;21(1):122-9. doi: 10.1007/s00330-010-1895-3. Epub 2010 Aug 26. Eur Radiol. 2011. PMID: 20737152 Clinical Trial.
-
Efficacy and safety of hyaluronic-polidocanol foam in sclerotherapy for head and neck venous malformations.Front Neurol. 2024 Aug 16;15:1444896. doi: 10.3389/fneur.2024.1444896. eCollection 2024. Front Neurol. 2024. PMID: 39220735 Free PMC article.
-
Single Blind, Randomised Study Regarding the Treatment of the Telangiectasia of the Lower Limbs (C1EAP) Using Polidocanol 0,5%, 1%, and Nd:YAG Laser.Curr Health Sci J. 2020 Apr-Jun;46(2):141-149. doi: 10.12865/CHSJ.46.02.07. Epub 2020 Jun 30. Curr Health Sci J. 2020. PMID: 32874686 Free PMC article.
-
Treatment of varicose veins.Curr Treat Options Cardiovasc Med. 2009 Apr;11(2):91-103. doi: 10.1007/s11936-009-0010-z. Curr Treat Options Cardiovasc Med. 2009. PMID: 19289022
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous